These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29558525)

  • 1. Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls.
    Sanders JM; Steverson AB; Pawlowski AE; Schneider D; Achenbach CJ; Lloyd-Jones DM; Feinstein MJ
    PLoS One; 2018; 13(3):e0194754. PubMed ID: 29558525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between human immunodeficiency virus serostatus and the prevalence of atrial fibrillation.
    Osuji N; Haberlen SA; Ashikaga H; Brown TT; Feinstein MJ; Witt MD; Magnani JW; Soliman EZ; Wu KC; Post WS
    Medicine (Baltimore); 2021 Jul; 100(29):e26663. PubMed ID: 34398028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity.
    Hsu JC; Li Y; Marcus GM; Hsue PY; Scherzer R; Grunfeld C; Shlipak MG
    J Am Coll Cardiol; 2013 Jun; 61(22):2288-95. PubMed ID: 23563125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing prevalence of atrial fibrillation and flutter in the United States.
    Naccarelli GV; Varker H; Lin J; Schulman KL
    Am J Cardiol; 2009 Dec; 104(11):1534-9. PubMed ID: 19932788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT.
    Haywood LJ; Davis BR; Piller LB; Cushman WC; Cutler JA; Ford CE; Simpson LM; Ghosh A; Soliman EZ; Wright JT;
    J Natl Med Assoc; 2017 Autumn; 109(3):172-181. PubMed ID: 28987246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.
    Peyrol M; Sbragia P; Bonello L; Lévy S; Paganelli F
    Arch Cardiovasc Dis; 2011 Oct; 104(10):530-5. PubMed ID: 22044706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhythmic drug medication.
    Brembilla-Perrot B; Girerd N; Sellal JM; Olivier A; Manenti V; Villemin T; Beurrier D; DE Chillou C; Louis P; Selton O; DE LA Chaise AT
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):813-820. PubMed ID: 24654647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy.
    Brembilla-Perrot B; Schwartz J; Huttin O; Frikha Z; Sellal JM; Sadoul N; Blangy H; Olivier A; Louis S; Kaminsky P
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):329-35. PubMed ID: 24117873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.
    Dasari TW; Pavlovic-Surjancev B; Patel N; Williams AA; Ezidinma P; Rupani A; Sinacore JL; Heroux AL
    Am J Cardiol; 2010 Sep; 106(5):737-41. PubMed ID: 20723655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis.
    Romero J; Diaz JC; Di Biase L; Kumar S; Briceno D; Tedrow UB; Valencia CR; Baldinger SH; Koplan B; Epstein LM; John R; Michaud GF; Stevenson WG
    J Interv Card Electrophysiol; 2017 Apr; 48(3):307-315. PubMed ID: 28070875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.
    Pastori D; Mezzaroma I; Pignatelli P; Violi F; Lip GYH
    Br J Clin Pharmacol; 2019 Mar; 85(3):508-515. PubMed ID: 30575989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High familial risk of atrial fibrillation/atrial flutter in multiplex families: a nationwide family study in Sweden.
    Zöller B; Ohlsson H; Sundquist J; Sundquist K
    J Am Heart Assoc; 2012 Dec; 2(1):e003384. PubMed ID: 23525409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of International Classification of Diseases, Tenth Revision, codes for atrial fibrillation/flutter in critically ill patients with sepsis.
    Persaud P; Rudoni MA; Duggal A; Miyashita S; Lanspa M; Dugar S
    Anaesth Crit Care Pain Med; 2024 Aug; 43(4):101398. PubMed ID: 38821159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.
    Peltzer B; Manocha KK; Ying X; Kirzner J; Ip JE; Thomas G; Liu CF; Markowitz SM; Lerman BB; Safford MM; Goyal P; Cheung JW
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3077-3085. PubMed ID: 33017083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
    Amin AN; Jhaveri M; Lin J
    Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring.
    Primo J; Gonçalves H; Macedo A; Russo P; Monteiro T; Guimarães J; Costa O
    Rev Port Cardiol; 2017; 36(7-8):535-546. PubMed ID: 28709762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry.
    Rix TA; Riahi S; Overvad K; Lundbye-Christensen S; Schmidt EB; Joensen AM
    Scand Cardiovasc J; 2012 Jun; 46(3):149-53. PubMed ID: 22397620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).
    Steuter JA; Villanueva ML; Loberiza FR; Armitage JO; Bociek RG; Ganti AK; Tarantolo SR; Vose JM; Easley A; Bierman PJ
    Bone Marrow Transplant; 2013 Jul; 48(7):963-5. PubMed ID: 23222385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.